SEO URLwww.firestrike.ai/deals/optimed-zylox-tonbridge-medical-technology-acquisition-2026-3
acquisitionAnnounced · Jan 19, 2026medical technologySource · MagazinesArticle · Factual
Zylox-Tonbridge Medical Technology acquires optimed
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
—
Target
optimed
Ettlingen, Baden-Wuerttemberg
Acquirer
Zylox-Tonbridge Medical Technology
Full Acquisition
Status
Pending
Zylox-Tonbridge Medical Technology agreed to acquire optimed. Reported deal value: Undisclosed. Status: Pending. Sector: medical technology. Target headquarters context: Ettlingen, Baden-Wuerttemberg, Germany.
This page summarizes publicly available information about the transaction as of 2026-01-19. Figures and status may change as filings and press coverage update.
Zylox - Tonbridge , a Hong Kong-listed company specialising in neurovascular and peripheral vascular interventional products, has agreed to acquire German medical technology company Optimed
Deal timeline
Announced
Jan 19, 2026 · medicaldevice-network.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in medical technology. Figures and status may change as sources update.
Sources: medicaldevice-network.com · Primary article · FireStrike proprietary index